First Advantage Corp. FA 深 沪
已收盘 05-15 16:00:00 美东时间
14.87
+0.100
+0.68%
华盛通- 最 高15.28
- 今 开14.75
- 成交量 77.51万股
- 最 低 14.57
- 昨 收 14.77
- 总市值 25.64亿
- 52周最高 19.01
- 市盈率 静 --
- 换手率 0.45%
- 52周最低 8.82
- 委 比 37.50%
- 总股本 1.72亿
- 历史最高 23.23
- 量 比 0.47
- 振 幅 4.81%
- 历史最低 8.57
- 每 手 1
- 风险率 2.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Barclays Maintains Overweight on First Advantage, Raises Price Target to $20
Barclays analyst Manav Patnaik maintains First Advantage (NASDAQ:FA) with a Overweight and raises the price target from $15 to $20.
05-08 22:55
First Advantage shares are trading higher after the company reported better-than-expected Q1 financial results.
First Advantage shares are trading higher after the company reported better-tha...
05-07 20:43
First Advantage Affirms FY2026 Adj EPS Guidance of $1.15-$1.25 vs $1.20 Est; Affirms FY2026 Sales Guidance of $1.625B-$1.700B vs $1.655B Est
First Advantage (NASDAQ:FA) affirms FY2026 Adj EPS guidance from $1.15-$1.25 to $1.15-$1.25 vs $1.20 analyst estimate. Affirms FY2026 sales outlook from $1.625 billion-$1.700 billion to $1.625 billion-$1.700 billion vs
05-07 18:04
First Advantage Q1 Adj. EPS $0.26 Beats $0.21 Estimate, Sales $385.200M Beat $372.602M Estimate
First Advantage (NASDAQ:FA) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.21 by 23.81 percent. This is a 52.94 percent increase over earnings of $0.17 per share from the
05-07 18:04
AI ETFs Hit 52-Week Highs—But The Math Just Doesn't Add Up
AI ETFs hit 52-week highs as investors piled into the AI trade, but weak corporate ROI visibility raises questions about the sustainability of the rally.
05-06 03:13
Jamie Dimon Sounds The Alarm On Critical Mineral Vulnerability
JPMorgan expands $1.5T security initiative to Europe as Jamie Dimon warns fragile critical mineral supply chains threaten global stability.
04-21 18:32
Apple To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts have changed their outlook on top names. For full analyst rating changes, including upgrades/downgrades, see analyst ratings page.
04-14 19:54
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
